Taher A - Search Results

1

Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.

Fathallah H, Taher A, Bazarbachi A, Atweh GF. Fathallah H, et al. Among authors: taher a. Blood Cells Mol Dis. 2009 Jul-Aug;43(1):58-62. doi: 10.1016/j.bcmd.2009.02.006. Epub 2009 Apr 5. Blood Cells Mol Dis. 2009. PMID: 19346141 Free PMC article.

2

High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon.

Taher A, Khalil I, Abou-Merhi R, Shamseddine A, Bazarbachi A. Taher A, et al. Thromb Haemost. 2003 May;89(5):945-6. Thromb Haemost. 2003. PMID: 12719795 No abstract available.

3

Thalassemia intermedia: revisited.

Taher A, Isma'eel H, Cappellini MD. Taher A, et al. Blood Cells Mol Dis. 2006 Jul-Aug;37(1):12-20. doi: 10.1016/j.bcmd.2006.04.005. Epub 2006 Jun 5. Blood Cells Mol Dis. 2006. PMID: 16737833 Review.

4

Thalassemia and hypercoagulability.

Taher AT, Otrock ZK, Uthman I, Cappellini MD. Taher AT, et al. Blood Rev. 2008 Sep;22(5):283-92. doi: 10.1016/j.blre.2008.04.001. Epub 2008 Jun 3. Blood Rev. 2008. PMID: 18511163 Review.

5

Absence of JAK2 V617F mutation in thalassemia intermedia patients.

Taher A, Shammaa D, Bazarbachi A, Itani D, Zaatari G, Greige L, Otrock ZK, Mahfouz RA. Taher A, et al. Mol Biol Rep. 2009 Jul;36(6):1555-7. doi: 10.1007/s11033-008-9350-0. Epub 2008 Sep 10. Mol Biol Rep. 2009. PMID: 18781401

6

Effects of divalproex sodium on hemoglobin level.

Taher AT, Musallam KM, Nasreddine W, Perrine SP, El-Hajj TI, Beydoun A. Taher AT, et al. Blood Cells Mol Dis. 2009 Jul-Aug;43(1):49-52. doi: 10.1016/j.bcmd.2009.01.015. Epub 2009 Mar 1. Blood Cells Mol Dis. 2009. PMID: 19254854

7

Oral contraceptive pills and inherited thrombophilia in a young woman with deep venous thrombosis.

Mahfouz RA, Otrock ZK, Ghasham MA, Sabbagh AS, Taher AT, Bazarbachi A. Mahfouz RA, et al. Among authors: taher at. East Mediterr Health J. 2009 Jan-Feb;15(1):235-8. East Mediterr Health J. 2009. PMID: 19469449 Free article. Review. No abstract available.

8

Long-term outcome of adult acute lymphoblastic leukemia in Lebanon: a single institution experience from the American University of Beirut.

Charafeddine KM, Hatoum HA, Otrock ZK, Mahfouz RA, Salem ZM, Shamseddine AI, Taher AT, El-Saghir NS, Bazarbachi A. Charafeddine KM, et al. Among authors: taher at. Hematol Oncol Stem Cell Ther. 2009;2(2):333-9. doi: 10.1016/s1658-3876(09)50021-0. Hematol Oncol Stem Cell Ther. 2009. PMID: 20118056 Free article. Clinical Trial.

9

JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in Lebanon.

Mahfouz RA, Hoteit R, Salem Z, Bazarbachi A, Mugharbel A, Farhat F, Ziyadeh A, Ibrahim A, Taher A. Mahfouz RA, et al. Among authors: taher a. Genet Test Mol Biomarkers. 2011 Apr;15(4):263-5. doi: 10.1089/gtmb.2010.0136. Epub 2011 Jan 3. Genet Test Mol Biomarkers. 2011. PMID: 21198321

10

Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with β thalassemia intermedia.

Musallam KM, Taher AT, Duca L, Cesaretti C, Halawi R, Cappellini MD. Musallam KM, et al. Blood Cells Mol Dis. 2011 Dec 15;47(4):232-4. doi: 10.1016/j.bcmd.2011.07.005. Epub 2011 Aug 23. Blood Cells Mol Dis. 2011. PMID: 21865063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

953 results

Search Page